Intravenous Immune Globulin Therapy in Dermatomyositis.
Amato AA.
N Engl J Med. 2022 Oct 6;387(14):1320-1321. doi: 10.1056/NEJMe2209117.
A New Intravenous Immune Globulin: Novel or Not?
Bates BN, Olah ME.
Ann Pharmacother. 2021 Jan;55(1):117-122. doi: 10.1177/1060028020934722. Epub 2020 Jun 21.
Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA, Yarsley RL.
Ann Pharmacother. 2021 Feb;55(2):198-215. doi: 10.1177/1060028020943542. Epub 2020 Jul 21.
Intravenous immune globulin in recurrent abortion.
Heine O, Mueller-Eckhardt G.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):39-42.
Intravenous immune globulin in myasthenia gravis.
Gajdos P.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):49-51.
Trial of Intravenous Immune Globulin in Dermatomyositis.
Werth VP, Fiorentino DF, Vleugels RA.
N Engl J Med. 2023 Jan 5;388(1):94. doi: 10.1056/NEJMc2214285.
Intravenous immune globulin therapy for neurologic diseases.
Dalakas MC.
Ann Intern Med. 1997 May 1;126(9):721-30. doi: 10.7326/0003-4819-126-9-199705010-00008.
Intravenous immune globulin in autoimmune and inflammatory diseases.
Gelfand EW.
N Engl J Med. 2012 Nov 22;367(21):2015-25. doi: 10.1056/NEJMra1009433.
Intravenous immune globulin in primary immunodeficiency.
Haeney M.
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):11-5.
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.
Ammann EM, Haskins CB, Fillman KM, Ritter RL, Gu X, Winiecki SK, Carnahan RM, Torner JC, Fireman BH, Jones MP, Chrischilles EA.
Am J Hematol. 2016 Jun;91(6):594-605. doi: 10.1002/ajh.24358. Epub 2016 Apr 24.
